TY - JOUR
T1 - A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows
T2 - A Report of the Association for Molecular Pathology Training and Education Committee
AU - Rosenbaum, Jason N.
AU - Berry, Anna B.
AU - Church, Alanna J.
AU - Crooks, Kristy
AU - Gagan, Jeffrey R.
AU - López-Terrada, Dolores
AU - Pfeifer, John D.
AU - Rennert, Hanna
AU - Schrijver, Iris
AU - Snow, Anthony N.
AU - Wu, David
AU - Ewalt, Mark D.
N1 - Funding Information:
The authors and the Association for Molecular Pathology thank Lucia P. Barker, Kathleen Carmody, Linda Jeng, Annette Kim, Roger Klein, Mahesh Mansukhani, Federico Monzon, Laura J. Tafe, Vivianna Van Deerlin, and Cecilia Yeung in bringing this article to fruition.
Publisher Copyright:
© 2021 Association for Molecular Pathology and American Society for Investigative Pathology
PY - 2021/10
Y1 - 2021/10
N2 - Molecular genetic pathology (MGP) is a subspecialty of pathology and medical genetics and genomics. Genomic testing, which is defined as that which generates large data sets and interrogates large segments of the genome in a single assay, is increasingly recognized as essential for optimal patient care through precision medicine. The most common genomic testing technologies in clinical laboratories are next-generation sequencing and microarray. It is essential to train in these methods and to consider the data generated in the context of the diagnosis, medical history, and other clinical findings of individual patients. Accordingly, updating the MGP fellowship curriculum to include genomics is timely, important, and challenging. At the completion of training, an MGP fellow should be capable of independently interpreting and signing out results of a wide range of genomic assays and, given the appropriate context and institutional support, of developing and validating new assays in compliance with applicable regulations. The Genomics Task Force of the MGP Program Directors, a working group of the Association for Molecular Pathology Training and Education Committee, has developed a genomics curriculum framework and recommendations specific to the MGP fellowship. These recommendations are presented for consideration and implementation by MGP fellowship programs with the understanding that MGP programs exist in a diversity of clinical practice environments with a spectrum of available resources.
AB - Molecular genetic pathology (MGP) is a subspecialty of pathology and medical genetics and genomics. Genomic testing, which is defined as that which generates large data sets and interrogates large segments of the genome in a single assay, is increasingly recognized as essential for optimal patient care through precision medicine. The most common genomic testing technologies in clinical laboratories are next-generation sequencing and microarray. It is essential to train in these methods and to consider the data generated in the context of the diagnosis, medical history, and other clinical findings of individual patients. Accordingly, updating the MGP fellowship curriculum to include genomics is timely, important, and challenging. At the completion of training, an MGP fellow should be capable of independently interpreting and signing out results of a wide range of genomic assays and, given the appropriate context and institutional support, of developing and validating new assays in compliance with applicable regulations. The Genomics Task Force of the MGP Program Directors, a working group of the Association for Molecular Pathology Training and Education Committee, has developed a genomics curriculum framework and recommendations specific to the MGP fellowship. These recommendations are presented for consideration and implementation by MGP fellowship programs with the understanding that MGP programs exist in a diversity of clinical practice environments with a spectrum of available resources.
UR - http://www.scopus.com/inward/record.url?scp=85116158813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116158813&partnerID=8YFLogxK
U2 - 10.1016/j.jmoldx.2021.07.001
DO - 10.1016/j.jmoldx.2021.07.001
M3 - Review article
C2 - 34245921
AN - SCOPUS:85116158813
SN - 1525-1578
VL - 23
SP - 1218
EP - 1240
JO - Journal of Molecular Diagnostics
JF - Journal of Molecular Diagnostics
IS - 10
ER -